AI-generated summary
This systematic review of randomized clinical trials examined whether photobiomodulation prevents recurrent herpes labialis, identifying three eligible studies. The authors report that two trials found fewer recurrences after photobiomodulation and one found no difference, with inconsistent results for severity and duration. They note the evidence is of low certainty due to small samples, incomplete blinding, and varied laser parameters.
- Studies included
- 3
- Who or what was studied
- People with recurrent herpes labialis (cold sores), as included in three randomized clinical trials
- Limits stated in the abstract
- The authors state the certainty of evidence is low due to small sample sizes, incomplete blinding, and variations in laser parameters and comparators, and that definitive clinical recommendations are not possible.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journal.einstein.br.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Systematic review, Blinding, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.